CD274 and neoplasm: Recent evidence suggests that sEVs released by cancer cells not only carry PD-L1 on their surface but are also able to induce its expression in myeloid cells (Figure 1C), thus further contributing to enhancing the immunosuppressive status of the tumor microenvironment (TME).